This page was reviewed under our medical and editorial policy by
Maurie Markman, MD, President, Medicine & Science
This page was updated on May 23, 2022.
A thorough and accurate cancer diagnosis is critical to determining a uterine cancer patient’s treatment plan. At City of Hope, our multidisciplinary team of experts use a broad range of tests and tools designed for diagnosing uterine cancer. Cancer type, stage and overall health are considered when developing a treatment plan tailored to each patient’s needs and goals. Imaging and laboratory tests will be used to monitor the patient’s response to treatment, and our cancer experts will modify the care plan when needed.
The two primary types of uterine cancer are:
For those experiencing symptoms of endometrial cancer, doctors may recommend a physical and pelvic examination. The main tests to detect endometrial cancer fall into two categories—ultrasound and endometrial tissue sampling.
Ultrasound uses sound waves to create images of the organs in the reproductive system and may be done externally or internally:
Endometrial tissue sampling involves removing a small amount of tissue from the endometrium and may be done with one of the following procedures:
Endometrial biopsy is the most common endometrial cancer test. The doctor places a thin, flexible tube through the cervix into the uterus and uses suction to remove a small piece of the endometrium. The suctioning procedure typically takes a minute or less. The doctor may prescribe a nonsteroidal anti-inflammatory drug (NSAIDs) such as ibuprofen ahead of time or give an injection of local anesthetic to numb the area before the procedure.
Dilation & curettage (D&C) with hysteroscopy involves dilating (or increasing the opening of) the cervix and using a spoon-shaped tool called a curette to remove a uterine tissue sample. Anesthesia may be given before a D&C to minimize discomfort.
Doctors may also recommend blood tests to help diagnose or stage endometrial cancer, including:
Advanced genomic testing is the most common lab test for uterine cancer. The analysis examines a tumor for DNA alterations that are driving the growth of cancer. By identifying the mutations that occur in a cancer cell's genome, we may better understand the tumor behavior, and we may be able to tailor a treatment based on these findings.
CA-125 test measures the amount of the CA-125 protein in the blood. High amounts of CA-125 may indicate uterine, ovarian, fallopian tube or peritoneal cancer, as well as less serious conditions such as endometriosis or abdominal inflammation. We often use this test in combination with other diagnostic methods. A CA-125 test is also used during cancer treatment. High levels of CA-125 that begin to decline may indicate that the treatment is having a positive effect. If the level instead continues to rise, the doctor may consider changing the treatment regimen.
Uterine sarcomas are often found during or following a surgical procedure to address what appeared to be benign fibroid tumors. In some cases, they may be diagnosed because of a patient’s symptoms.
Many of the same methods used to detect and diagnose endometrial cancer are also utilized for detecting uterine sarcoma, including:
Other kinds of tests may be needed to determine whether uterine sarcoma has spread beyond the uterus. These include:
If your doctor schedules uterine cancer testing, it’s important to follow all preparation steps. These may include arranging for someone to drive home afterward. Be aware of any guidelines to follow once home, such as getting rest and monitoring for side effects. Make sure you know what to watch for and when to call your care team.